Robert Brooke

CEO, Co-founder

Former hedge fund analyst at Bristol Capital for over 50 direct healthcare investments; Experienced biotech entrepreneur, Founder of Genesis, now Lion Biotech (NASDAQ:LBIO), Co-Founder of Intervene Immune. B.S. in Electrical Eng., Georgia Tech; M.S. in Biomedical Eng., UCLA.


Richard McKilligan, JD, MBA


Ex-Morgan, Lewis, & Bockius LLP, State Bars in CA and NY, CPA (inactive). JD from Cornell, MBA from Univ of Chicago, BS in Accounting from Univ of Illinois.


Avtar Dhillon, MD

Chairman & Co-founder

Chairman, Inovio Pharmaceuticals, Oncosec Medical, and Arch Therapeutics. Raised $200M in public markets over last 10 years. Former venture capitalist and family physician for over 10 years.


Anthony Maida, PhD, MBA

Director, Chair of Audit Committee

Senior Vice President, Clinical Research, Northwest Bio. MBA, MA in Toxicology, PhD in Immunology.


Brandon Zipp, PhD

Director of R&D, Scientific Co-founder

10 years research experience with glucosyltransferase enzymes. Developer of UGT biosynthesis platform. Ph.D., Biochem & Molecular Biology, Univ. of California Davis.

Tracy Rockney

Senior Regulatory Advisor

Led regulatory team at Shire (NASDAQ:SHPG) for LIALDA, an approved drug for IBD. Former VP of Reg. Affairs at Abbvie (NYSE:ABBV).

Get in Touch  Contact Vitality Biopharma